• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Design and Evaluation of Albumin Mutants for Clinical Application

Research Project

Project/Area Number 11694298
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Biological pharmacy
Research InstitutionKUMAMOTO UNIVERSITY

Principal Investigator

OTAGIRI Masaki  Fac.Pharm.Sci., KUMAMOTO UNIVERSITY Prof., 薬学部, 教授 (80120145)

Co-Investigator(Kenkyū-buntansha) TANASE Sumio  Sch.Med.Sci., KUMAMOTO UNIVERSITY Asso.Prof., 医学部, 助教授 (20112401)
KAI Hirofumi  Fac.Pharm.Sci., KUMAMOTO UNIVERSITY Assoc.Prof., 薬学部, 助教授 (30194658)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥7,300,000 (Direct Cost: ¥7,300,000)
Fiscal Year 2000: ¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 1999: ¥3,900,000 (Direct Cost: ¥3,900,000)
KeywordsAlbumin preparation / Site-directed mutagenesis / Molecular design / Artificial blood / Functional evaluation / Blood preparation / Clinical application
Research Abstract

International collaboration work for reducing the rate of albumin preparations usage was undertaken to develop a safe and effective recombinant albumins. The results obtained are as follow :
1) Two single-mutants (K199A, K525A) were produced. The recombinant albumins were correctly folded, as evidenced by the fact that they showed similar patterns as the native albumin in the far- and near-UV CD spectrum as well as reactivity towards polyclonal anti-serum raised against native albumin.
2) Thermal denaturation experiments by using GdnCl and DSC revealed no significant difference in conformational stability for native and mutant albumins.
3) The ligand binding properties and esterase-like activity of the albumin mutants were nearly the same as those for the native albumin.
4) The plasma levels of the albumin mutants labeled with ^<125>I after intravenous bolus injections to rats showed two-phase profiles but their half-lives were shorten than that for the native albumin.
5) Dr.Kragh-Hansen of Aarhus University visited Kumamoto University twice (Oct.23-Nov.7, 1999 ; May 5-Oct.29, 2000) to discuss about pharmacokinetic and biological properties of the albumin mutants. Dr.Curry of Imperial College also visited Kumamoto University (Sep.27-Oct.26, 2000) to discuss about structural characterization of the albumin mutants.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (33 results)

All Other

All Publications (33 results)

  • [Publications] K.Yamasaki et al: "Interactive binding to the two principal ligand binding sites of HSA : effect of the N-B transition"Biochimca et Biophysica Acta. 1432. 313-323 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] V.T.G.Chung et al: "Helix of subdomain IIIA of HSA is the region prinarily photolabeled by ketoprofen"Biochimica et Biophysica Acta. 1434. 18-30 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Y.Tsutsumi: "Decreased bilirubin binding capacity in usemic serum caused by an accumnlation of furan dicarboxylic acid"Nephron. 85(1). 60-64 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] H.Watanabe et al: "Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity"Biochemical Journal. 349. 813-819 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] T.Sakai et al: "Interaction between indoxyl sulfate, a typical usemic toxin bound to site II, and Ligands bound to site I of HSA"Pharmaceutical Research. 18(4)(in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] H.Watanabe et al: "Conformational stability and warfarin binding properties of human serum albumin studied by recombinant mutants"Biochemical Journal. (in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 丸山徹,小田切優樹(分担)沢田康文 他(編集): "医薬品の適正使用のための臨床薬物動態"じほう. 834 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 小田切優樹,今井輝子(分担)永井恒司(監修): "新・ドラッグデリバリーシステム"シーエムシー. 227 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Watanabe H, et al.: "Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants."Biochem.J.. 358 (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sakai T, et al.: "Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin."Pharm Res.. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Naito S, et al.: "Determination of reduced, protein-unbound, and total concentrations of N-acetyl-1-cysteine and 1-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography."Anal Biochem.. 290(2). 251-9 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Chuang VTG, et al.: "Flunitrazepam a 7-nitro-1, 4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin."Biochim Biophys Acta.. 1546. 337-345 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Watanabe H, et al.: "Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity."Biochem J.. 349(3). 813-9 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsutsumi Y, et al.: "Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid."Nephron.. 85(1). 60-4 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kawasaki C, et al.: "Charcoal hemoperfusion in the treatment of phenytoin overdose."Am J Kidney Dis.. 35(2). 323-6 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Chuang VTG, et al.: "Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety."Biochim Biophys Acta.. 1434(1). 18-30 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamasaki K, et al.: "Interactive binding to the two principal ligand binding sites of human serum albumin : effect of the neutral-to-base transition."Biochim Biophys Acta.. 1432(2). 313-23 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsutsumi Y, et al.: "Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin."Pharm Res.. 16(6). 916-23 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] K.Yamasaki et al: "Interactive binding to the two Principal ligand binding sites of HSA : effect of the N-B transition"Biochimica et Biophysica Acta. 1432. 313-323 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] V.T.G.Chung et al: "Helix of subdomain III A of HSA is the region primarily Photolabeled by ketoprofen"Biochimica et Biophysica Acta. 1434. 18-30 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Y.Tsutsumi: "Decreased bilirubin binding capacity in uremic serum caused by an aaccumulation of furan dicarboxylic acid"Nephron. 85(1). 60-64 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] H.Watanabe et al: "Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity"Biochemical Journal. 349. 813-819 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] T.Sakai et al: "Interaction between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of HSA"Pharmaceutical Research. 18(4)(in press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] H.Watanabe et al: "Conformational stability and warfarin binding properties of human serum albumin studied by recombinant mutants"Biochamical Journal. (in press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] 丸山徹,小田切優樹(分担)沢田康文 他(編集): "医薬品の適正使用のための臨床薬物動態"じほう. 834 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 小田切優樹,今井輝子(分担)永井恒司(監修): "新・ドラッグデリバリーシステム"シーエムシー. 227 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Y.Tsutsumi et al: "Interaction between two earboxlate endogcous substances, bilirubin and on uremic toxin, CMPF, on HSA"Pharmaceutical Research. 16・(6). 916-923 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] K.Yamasaki et al: "Interactive binding to the two principal ligand binding siteo of HSA: effect of the N-B transition"Biochimica Biophysica Acta. 1432. 313-323 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] V.T.G.Chuang et al: "Helix of subdomain IIIA of HSA is the region primainly photolabelet by betoproten"Biochimica Biophysica Acta. 1434. 18-30 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] T.Sakai et al: "Stereoselective serum protein binding of be to profen in liver diseises"Enantiomer. 4・(5). 477-482 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] C.Kawasaki et al: "Charcoal hemoperfusion in the treatment of phenytoin onerdose"Amcical Journul of kidney Desease. 35(2). 323-326 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Y.Tsutsumi: "Decreased bilirubin-binding capacity in uremicserum caused by an accumulation of furan dicarboxylic acid"Nephrom. 84・(3)(in press). (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] 小田切優樹分担(永井恒司監修): "新・ドラッグデリバリーシステム"シーエムシ. 227 (2000)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi